The Leadership Team at ProMIS Neurosciences is responsible for setting the strategic direction and operational oversight of the company’s initiatives in developing precision therapeutics for neurodegenerative diseases. Comprised of key executives such as the CFO, President, COO, CDO, and CSO, this team collaborates to drive research and development projects, ensure financial sustainability, and align business objectives with scientific advancements to enhance the effectiveness of treatments and diagnostics for conditions like Alzheimer’s and ALS.
View all